NR4A1 and breast cancer: Surgery, chemotherapy, and radiotherapy are commonly used for all types of breast cancer, while endocrine therapies are employed for hormone receptor-positive cases and anti-HER2 therapy for HER2+ cases, targeting specific molecular subtypes [2, 3].